FibroGen (FGEN) Misses Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. NVT
8. SPY
9. AAPL
10. LITE

Go back to FibroGen (FGEN) Misses Q1 EPS by 6c

FibroGen Reports First Quarter 2023 Financial Results

May 8, 2023 4:01 PM EDT

 Topline Data From Four Phase 3 Trials Expected Through 3Q 2023

 Completed Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value

Entered Into Exclusive License for FOR46 with Fortis Therapeutics

SAN FRANCISCO, May 08, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the first quarter 2023 and provided an update on the companys recent developments.

We look forward to reporting topline data from four pivotal phase 3 trials through the... More